![]() |
|
|
Authored by
Medical Director The Faculty Disclosure Policy of the Albert Einstein College of Medicine requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the activity. It is required by the ACCME that any mention of unlabeled use of a commercial product or device or an investigational use not yet approved by the FDA be disclosed to participants. Terry Treadwell, MD, has received research support from and/or participated in the Speakers Bureau for Ortho-McNeil Pharmaceutical and Novartis Pharmaceuticals Corporation. |
|
![]() |
|
|
Authored by
Assistant Professor of Dermatology The Faculty Disclosure Policy of the Albert Einstein College of Medicine requires that faculty participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company that might pose a potential, apparent, or real conflict of interest with regard to their contribution to the activity. It is required by the ACCME that any mention of unlabeled use of a commercial product or device or an investigational use not yet approved by the FDA be disclosed to participants. Robert S. Kirsner, MD, has received grant/research support from Organogenesis and has served on the Speakers Bureau for Ortho-McNeil Pharmaceutical and Novartis Pharmaceuticals Corporation.
|
|